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Methods: Between 1988 and 1995, 60 patients with complex cardiac anom- 
alies underwent a total extracardiac cavopulmonary connection, a combi- 
nation of a bidirectional cavopulmonary anastomosis with an extracardiac 
conduit interposition between the inferior vena eava and pulmonary 
arteries, except in one patient in whom direct anastomosis was possible. In 
40 patients the total extracardiac avopu!monary connection followed 
preliminary bidirectional cavopulmonary anastomosis, associated with a 
modified Damus-Kaye-Stansel anastomosis in 16. The conduits were con- 
strutted of Dacron fabric (n = 34), homografts in = 3), and polytetrafluo- 
roethylene (n = 22). Results: Total early failure rate was 15% (n = 9). Six 
patients died, and three more had conduit takedown owing to pulmonary 
artery stenosis and hypoplasia (n = 2) and severe atrioventricular valve 
regurgitation (n = 1). Two other patients required anastomosis revision 
owing to stricture. In a mean follow-up of 48 months (6 to 86 monthe) there 
were no late deaths (actuarial 5-year survival 88% --- 4%); 52 of 54 patients 
are in New York Heart Association class I or II. Two patients required 
pulmonary artery balloon dilation or stent implantation, or both, after total 
extracardiac avopulmonary connection. Late tachyarrhythmias were de- 
tected in four of 54 patients: two had sick sinus syndrome with flutter 
necessitating a pacemaker implantation and two had recurrent flutter 
lactuarial 5-year arrhythmia-free rate 92% - 4%). Conduit pateney was 
evaluated by serial magnetic resonance imaging studies. Preliminary data 
showed a 17.8% - 7.6% mean reduction in conduit internal diameter 
during the first 6 months after total extraeardiac cavopulmonary eonnec- 
tion, with no progression over the next 5 years. Conclusion: These results 
demonstrate that the total extracardiac avopulmonary connection pro- 
vides good early and midterm results and may reduce the prevalence of late 
arrhythmias in patients undergoing the Fontan operation. (J Thorac 
Cardiovasc Surg 1997;114:1020-31) 
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The concept of bypassing the right ventricle was 
1 
/p roposed  by Rodbard and Wagner in 1949. In 
1951 Carlon, Mondini, and de Marchi 2 experimen- 
tally proved that the lungs could be perfused under 
venous pressure, and in 1958 Glenn 3 reported the 
first clinically successful anastomosis between the 
superior vena cava and the right pulmonary artery. 
Anastomoses between the inferior vena cava (IVC) 
and right pulmonary artery were also performed 
experimentally, but it was not until 1971 that Fontan 
and associates 4 reported the first successful total 
venous diversion to the lungs in a patient with 
tricuspid atresia. Since this original description, a 
number of modification to Fontan's operation have 
been described, which have simplified the operation 
and allowed its application to a variety of complex 
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Table I. Preoperative diagnosis 
Diagnostic group No. of patients Deaths Takedown Global failure Percent 
SV with LAW hypopla- 26 3 0 3 11 
sia or atresia 
Heterotaxy syndrome 12 3 2 5 41 (p = 0.01) 
Criss-cross hearts 6 0 0 0 0 
CAVC: 6 0 0 0 0 
(unbalanced CAVC) 2 
(DORV, CAVC) 4 
SV with LA juxtaposition 3 0 0 0 0 
CCA with situs solitus 7 0 1 1 14 
and dextrocardia 
Total 60 6 3 9 15 
SV,, Single ventricle; LAFV, left atrioventricular v lve; CAVC, common atrioventricular c nal; DORV,, double-outlet right ventricle; LA, left atrial; CCA, 
complex cardiac anomalies. 
cardiac anomalies.  Since 1988 we 5 have used a 
procedure  conceptual ly derived from the intraatr ial  
tunnel  approach reported by de Leval and col- 
leagues 6 and by Jonas and Castaneda.  7 This consists 
of an extracardiac conduit  placed between the IVC 
and the pulmonary artery associated with a bidirec- 
t ional cavopulmonary anastomosis,  so-cal led total 
extracardiac avopulmonary connect ion (TECC).  
Our  purpose is to review the first 7 years of experi- 
ence with TECC in complex cardiac anomalies. 
Patients and methods 
Patient population. Between November 1988 and June 
1995, 60 patients with complex cardiac anomalies under- 
went a modified Fontan operation by TECC. Preoperative 
diagnoses are grouped into six different categories and are 
listed in Table I. Fifty-five (91%) patients had previously 
undergone a total of 103 palliative operations before 
TECC, as shown in Figs. 1 and 2. Anomalies of systemic or 
pulmonary venous return (or both) were present in 27 
patients; six of them had total anomalous pulmonary 
venous connection (1 infradiaphragmatic, 1 supracardiac, 
and 4 intracardiac). In 38 patients the repair was staged by 
preliminary bidirectional cavopulmonary anastomosis 
(BCPA) that was bilateral in eight patients and associated 
with a modified Damus-Kaye-Stansel procedure to bypass a
subaortic obstruction i 16 patients. Two additional patients 
had a BCPA resulting from takedown of a previous Fontan 
shunt. Age and weight at operation averaged 73 -+ 35 
months (18 to 219 months) and 21 _+ 10.7 kg (10 to 73 kg); 
16 patients were younger than 4 years at operation. Mean 
pulmonary artery pressure was 12 + 4 mm Hg (range 4 to 24 
mm Hg), mean arterial oxygen saturation 82% _+ 7.5% 
(range 51% to 95%), and mean end-diastolic ventricular 
pressure 8 _+ 3 mm Hg (range 2 to 16 mm Hg). Mean 
hematocrit value was 51.6% _+ 6.4% (41% to 68%) and 
hemoglobin content 16.4 _+ 1.8 gm/dl (12.4 to 19.8 gm/dl). 
Surgical technique. After median sternotomy, cardio- 
pulmonary bypass was instituted by a single atrial cannula 
in 49 patients, by the IVC and common atrium in 3, and by 
double caval cannulation in the other 8. Deep hypother- 
mic circulatory arrest was used in 56 patients primarily to 
simplify the operation in patients who had had multiple 
previous interventions. No particular difficulties in venous 
drainage related to use of a single "left atrial" cannula 
during rewarming with the heart-lung machine were ob- 
served. In our recent experience (4 patients) the TECC 
was performed without aortic crossclamping byplacement 
of a right-angled cannula in the most proximal part of the 
intrathoracic IVC. Thirty-six patients received crystalloid 
cardioplegia nd 20 patients had blood cardioplegia. As 
previously reported, 5 a conduit segment is inserted after 
wide mobilization of the IVC and pulmonary arteries. The 
conduit was of woven Dacron fabric in 33 patients, 
polytetrafluoroethylene in 23, and nonvalved homograft 
in 3; the size was selected in relation to patient weight 
(Fig. 3). In one case of heterotaxy with interrupted IVC 
and azygos continuation, the conduit diverted only the 
hepatic venous blood to the pulmonary artery. In one 
patient with tricuspid atresia, transposition of the great 
arteries, and left appendage juxtaposition, a direct anas- 
tomosis between the IVC and the pulmonary artery was 
possible. Atrial septectomy, when required, was per- 
formed through the atrial stump of the transected IVC. 
Thirty-three associated procedures to TECC were per- 
formed (Table II). The mean aortic crossclamp time was 
37 minutes (range 15 to 72 minutes). The IVC-pulmonary 
artery connection was right-sided in 57 cases and left- 
sided in three. 
Data analysis. Data were analyzed and mean _+ stan- 
dard deviation of numeric values are presented. Associa- 
tion between the outcome events (death or failure) and 
preoperative and operative variables were analyzed uni- 
variately by X 2 or Fisher's exact test. Follow-up informa- 
tion was obtained in all patients by outpatient assessment 
or contact with primary physicians. Echocardiography, 
12-lead surface electrocardiograms, and 24-hour ambula- 
tory electrocardiographic monitoring were part of the 
yearly follow-up evaluation of all patients. Care was taken 
to monitor patients in whom clinical follow-up suggested 
an arrhythmia. Survival data and survival probability of 
time-related events were analyzed by the method of 
Kaplan and Meier. In 30 patients 60 magnetic resonance 
imaging studies were performed by means of a 0.2-tesla 
permanent magnet (Esaote MP 4000, Esaote Spa, 
Genova, Italy). Spin echo (TR = RR ECG interval, TE = 
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Fig. 1. Previous palliative operation in patients with reduced pulmonary blood flow (PBF). ASP, Atrial 
septectomy; SP, systemic-pulmonary; PA, pulmonary artery; BCPA, bidirectional cavopulmonary anasto- 
mosis. 
25 msec slice thickness often interfaced) sequences on 
axial, sagittal, and coronal planes were used to assess 
complete visualization of the prosthetic tube. In case of 
suspected parietal thrombosis, gradient repasing se- 
quences (TR = RR ECG interval, TE = 23 msec flip 
angle 45 degrees) were used to decrease flow artifacts. To 
evaluate the mean percentual decrease in tube diameter, 
we obtained the average of 10 to 20 diameter measure- 
ments in all planes. Furthermore, different points of 
maximal diameter decrease ventually present (proximal 
and distal anastomoses a well as third medium of the 
tube) were also evaluated. The examination time was 35 to 
60 minutes for each patient. 
Results 
Early results. Six hospital deaths occurred (10%) 
and the extracardiac onduit was taken down in 
three additional patients, for a total early failure 
rate of 15% (Table III). The cause of death was 
myocardial in four patients, all of whom had a 
combination of ventricular pressure or volume over- 
load with myocardial hypertrophy before TECC. 
Pulmonary artery distortion or hypoplasia ppeared 
to be the cause of death in two patients and of 
failure in an additional two. In the last patient, 
failure was mainly the result of atrioventricular valve 
regurgitation. Most of the patients received inotro- 
pic agents in the immediate postoperative period. 
The mean duration of mechanical ventilation was 
24.8 hours (range 1 to 96 hours), excluding seven 
patients in whom ventilatory support was prolonged 
(>100 hours). Mean arterial oxygen saturation in 
room air at discharge was 94% (range 88% to 99%). 
Prolonged pleural and peritoneal effusions, defined 
as more than 10 days of drainage or need for 
multiple drainage procedures, occurred in 18 pa- 
tients (33%). Two patients underwent early surgical 
revision of a stenotic anastomosis, between the 
superior vena cava and pulmonary artery in one and 
between the IVC and the conduit in the other. Two 
others underwent plication of a hemidiaphragm 
owing to phrenic nerve injury (bilateral in 1): all 
these patients had multiple palliative procedures 
before the TECC operation. Mediastinitis devel- 
oped in three patients. All patients were discharged 
receiving warfarin therapy for at least 6 months and 
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Fig. 2. Previous palliative operation (excluded patients with reduced pulmonary blood flow [PBF]). ASP, 
Atrial septectomy; TAPVC, total anomalous pulmonary venous connection; BCPA, bidirectional cavopul- 
monary anastomosis; PAB, pulmonary artery banding; DKS, Damus-Kaye-Stansel; PA, pulmonary artery; 
SP, systemic-pulmonary; PMK, pacemaker. 
then aspirin. In the follow-up eriod, neither throm- 
boembolic nor bleeding complications occurred ur- 
ing warfarin therapy. Statistical analysis (Table IV) 
revealed that heterotaxy s ndrome, total anomalous 
pulmonary venous connection, previous palliative 
operation to increase pulmonary blood flow, and 
operation done during years 1992 to 1993 proved to 
be risk factors for death or takedown. Atrioventric- 
ular valve regurgitation (2patients) and pulmonary 
artery distortion (4 patients), although apparent 
causes of failure in these patients, approached but 
did not reach statistical significance. Age less than 4 
years did not prove to be a risk factor for death or 
takedown. 
Late results. Follow-up to December 1995 was 
available in all 54 surviving patients. There were no 
late deaths, for an actuarial survival at 5 years of 
88% + 4% (Fig. 4). At a mean follow-up of 483 _+ 
24.7 months (range 6 to 86 months), 50 patients 
(92%) were in New York Heart Association func- 
tional class I, two in class II, and two in class III 
owing to moderate to severe atrioventricular valve 
regurgitation. Echocardiography showed normal 
systolic ventricular function in 49 patients. Thirty- 
one patients had reduced effort tolerance (60% to 
70% of normal age capacity) at the treadmill test 
performed 1 year after the operation. The three 
patients in whom the repair was taken down have 
remained cyanotic and have markedly reduced effort 
tolerance; they are now scheduled for a new TECC 
completion. Two patients underwent balloon dilata- 
tion of a stenotic superior cavopulmonary anasto- 
mosis and one had a stent placed in the left pulmo- 
nary artery. Three patients underwent drainage of a 
pleural and pericardial effusion 2 months after the 
operation, and two others had replacement of a 
malfunctioning pacemaker. One patient required 
device closure of a residual patent Blalock-Taussig 
shunt. Eighty-three percent of patients are free from 
reoperation at 5 years (Fig. 5). Although no routine 
neurologic examinations were done in these pa- 
tients, to the best of our knowledge no obvious 
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Fig. 3. Relationship between patient's weight and conduit size (patient's number in parentheses). Error 
bars indicate 1 standard eviation. 
Table II. Associate procedures to TECC 
No. 
Atrial septectomy 15 
PA plasty 9 
PMK implantation 6 
TAPVC repair 1 
AVV repair 1 
PMK substitution 1 
Total 33 
PA, Pulmonary artery; PMK, pacemaker; TAPVC, total anomalous pulmo- 
nary venous connection; AVV,, atrioventricular valve. 
neurologic omplications occurred in the follow-up 
period. 
• Arrhythmias 
Preoperative arrhythmias. A permanent pace- 
maker had been implanted in two patients before 
TECC because of congenital complete atrioventric- 
ular block. Pacemaker implantation was performed 
as an additional procedure to TECC in six patients 
for congenital complete atrioventricular block (4 
patients), sinoatrial block (1 patient), and sinus 
node dysfunction caused by a previous palliative 
Mustard operation (1 patient). 
Perioperative arrhythmias. Perioperative arrhyth- 
mias (less than 30 days after the Fontan operation) 
were observed in 13 patients. Nine patients had 
transient junctional rhythm with no hemodynamic 
consequences. 
Three patients had atrial flutter and underwent 
electrical cardioversion. One patient had junctional 
ectopic tachycardia that responded to antiarrhyth- 
mic drugs. None of these patients had arrhythmias 
at the time of hospital discharge. 
Major late postoperative arrhythmias (more than 
30 days after the Fontan procedure) occurred in 
four patients. All of them had recurrent atrial flutter 
(triggered by effort in one): two of the four patients 
are receiving antiarrhythmic drugs, and the other 
two, in whom the flutter was associated with symp- 
tomatic bradycardia (sick sinus syndrome), were 
treated by pacemaker implantation. Consequently, 
92.6% of patients are free from major arrhythmias 5 
years after the TECC (Fig. 6). Two additional 
patients had what we considered minor episodes of 
supraventricular or unifocal ventricular ectopy dis- 
covered by Holter monitoring. Preliminary results of 
transesophageal atrial pacing study, performed 2 years 
after the TECC operation, showed no inducible atrial 
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Table III. Cause of Fontan failure 
Age 
No. Preoperative diagnosis (mo) Previous palliation Outcome Cause 
1 DORV, hypoplastic LV 39 R BT shunt + ASP (10 days) Takedown, death Myocardial failure 
BCPA + ASP (23 mo) 
2 Asplenia 98 R BT shunt (15 days) Takedown, ECMO, death Myocardial failure 
BCPA (36 mo) 
3 DORV, hypoplastic LV 64 R BT shunt + ASP (2 too) Death Myocardial failure, 
Fontan (APC) (13 mo) AVV regurgitation 
Takedown, BCPA (13 mo) 
4 L-UVH, TGA 141 PAB + ASP (11 yr) Death Myocardial failure, 
DKS + BCPA (12 yr) PVOD? 
5 Asplenia 70 R BT shunt (3 days) Death PA stenosis/hypoplasia 
BCPA (15 mo) 
6 Asplenia 55 L BT shunt (8 mo) Takedown, ECMO, death PA stenosis/hypoplasia 
BCPA + PA plasty (24 mo) 
PA balloon dilatation (48 mo) 
7 Asplenia 34 TAPVC repair (1 mo) Takedown, AVV repair AVV regurgitation, 
pulmonary veins 
obstruction? 
8 Asplenia 98 L BT shunt (1 mo) Takedown, PA plasty PA stenosis/hyp0plasia 
BCPA (48 mo) 
9 Situs solitus, dextrocardia 46 BCPA (1 mo) Takedown, PA plasty 
(ccTGA, VSD, pulm atresia) 
PA stenosis/hypoplasia 
DORV, Double-outlet right ventricle; LV, left ventricle; L-UV/~, left univentricular heart; TGA, transposition f the great arteries; ccTGA, congenitally 
corrected transposition f the great arteries; VSD, ventricular septal defect; PA, pulmonary artery; R, right; BT, Blalock-Taussig; ASP, atrial septectomy; 
BCPA, bidirectional cavopulmonary nastomosis; APC, atriopulmonary connection; PAB, pulmonary artery banding; DKS, Damus-Kaye-Stansel; L, eft; 
TAPVC, total anomalous pulmonary venous connection; ECMO, extracorporeal membrane oxygenation; AVI/; atrioventricular v !ve; PVOD, pulmonary 
vascular obstructive disease. 
tachycardias among the first nine patients (different 
from the atriopulmonary connection operation). 
Magnetic resonance imaging. The magnetic res- 
onance imaging study showed in 20 patients amean 
reduction of the internal conduit diameter of 17.8% 
+ 7.6% during the first 6 months with no progres- 
sion over the following 5 years (17.2% _+ 6.17%,p = 
not significant). However, even the maximal internal 
diameter eduction found in 10 patients did not 
progress over time (32% _+ 7.9% vs 32.1% _+ 7.9%). 
Coronal plane images demonstrated shape modifi- 
cation from circular to elliptic, at some point within 
the conduit, in these 10 patients. 
Discussion 
Since the original report by Fontan, the concept 
has evolved that energy dissipation should be mini- 
mized while caval blood is diverted irectly into the 
pulmonary circuit, de Leval and coworkers 6 clearly 
demonstrated that head pressure losses and turbu- 
lence across cavities and corners cause significant 
energy dissipation. These authors therefore con- 
cluded that maximal forward output can be achieved 
by streamlining blood flow through avalveless right 
atrial tunnel of uniform caliber. In 1988 de Leval 
and associates 6 and Jonas and Castaneda 7 published 
their clinical experience with total cavopulmonary 
connection using a technique similar to that previ- 
ously described by Puga, Chiavarelli, and Hagler. 8
Associated with these changes in technique, mortal- 
ity and morbidity have progressively decreased to a 
present mortality rate for TCPC from 5% to 
15%. 9-12 The potential advantages of the TECC 
modification, as previously reported, 5' 13 include 
technical ease, no intraatrial manipulation or suture 
lines near the cavoatrial junction (potentially less 
arrhythmogenic), and satisfactory hemodynamic re- 
sults. TECC is particularly useful under anatomic 
circumstances in which atrial septation can be haz- 
ardous, such as in left juxtaposition of the atrial 
appendages, heterotaxy syndrome with anomalous 
systemic or pulmonary venous connections (or 
both), and hypoplasia of the left atrioventricular 
valve or complete atrioventricular canal. Our results 
with TECC in complex cardiac anomalies are similar 
to those of other groups, 9-12 with an early mortality 
of 10%. The definition and quantification of risk 
factors for patients undergoing a Fontan-type r pair 
remain elusive. Our analysis identified heterotaxy 
syndrome and operations done during the years 
1992 and 1993 to be predictive of poor outcome. 
The high rate of failure in heterotaxy syndrome , 
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Table IV. Statistical analysis 
No. of Early Total 
patients deaths (%) 95% CL p Value failure (%) 95% CL p Value 
Age 
< 4 yr 16 6.25 0-16 p = 1 18.7 3-34 p = 0.68 
> 4 yr 44 !1.4 0-24 13.6 0-27 
Heterotaxy 
Yes 12 25 8-42 p 0.08 41.7 22-61 p = 0.01 
No 48 6.25 0-16 8.3 0-19 
Dextrocardia 
Yes 19 5.3 0-14 p = 0.65 21.1 5-37 p - 0.44 
No 41 12.2 0-25 12.2 0-25 
CAVV 
Yes 17 17.6 3-33 p = 0.33 23.5 7-40 p = 0.25 
No 43 7 3-17 11.6 0-24 
LAVV hypoplasia/atresia 
Yes 30 10 2-22 p = 1 10 2-22 p = 0.30 
No 30 10 2-22 20 4-36 
TAPVC 
Yes 6 50 30-70 p = 0.01 66.7 48-85 p = 0.003 
No 54 5.6 0-15 9.3 0-21 
SVDA 
Yes 21 19 4-34 p = 0.17 28.6 11-46 p = 0.05 
No 39 5.1 4-14 7.7 3-18 
Previous SP shunt 
Yes 26 19.2 4-35 p = 0.Q7 23.1 7-40 p = 0.!5 
No 34 2.9 0-10 8.8 0-20 
Previous PAB 
Yes 16 6.25 0-16 p - 1 6.25 0-!6 p = 0.42 
No 44 11.3 0-24 18.1 3-33 
Previous PA procedure 
Yes 5 20 4-36 p = 0.42 20 4-36 p = 0.56 
No 55 9.1 0-20 14.5 1-28 
Previous ASP 
Yes 15 6.7 0-16 p = 1 13.3 0-27 p = 1 
No 45 11.1 0-23 15.6 1-30 
Previous BCPA 
Yes 40 15 1-29 p = 0.16 20 4-36 p = 0.24 
NO 20 0 0 5 0-14 
PA distortion 
Yes 15 !3.3 0-27 p = 0.63 26.7 9-44 p = 0.20 
No 45 8.9 0-20 1!.1 0-23 
AVV regurgitation 
Yes 5 20 4-36 p = 0.42 40 21-59 p = 0.15 
No 55 9.1 0-20 12.7 0-26 
PA pressure 
> 15 mm Hg 1i 18.1 3-33 p = 0.15 18.1 3-33 p = 0.49 
< 15 mm Hg 42 7.1 0-17 11.9 0-25 
Missed 7 14.3 1-28 28.6 11-46 
PA plasty at Fontan 
Yes 10 10 0-22 p = 1 20 4-36 p = 0.63 
No 50 10 2-22 14 0-28 
Total PA procedure 
Yes 13 15.4 1-30 p - 0.60 23.1 7-40 p = 0.39 
No 47 8.5 0-19 12.7 0-26 
ASP at Fontan 
Yes 16 6.25 0-16 p = 1 12.5 0-25 p = 1 
No 44 11.4 0-24 15.9 2-30 
Total ASP 
Yes 28 7.1 0-17 p = 0.67 10.7 0-23 p = 0.48 
No 32 12.5 0-25 18.7 3-34 
Years of operation 
1989-1991 28 3.5 4-11 10.7 0-23 
1992-1993 12 33.3 15-52 p = 0.01 33.3 15-52 p = 0.01 
1994-1995 20 5 0-14 10 0-22 
CL, Confidence limits; CAVV, common atrioventricular v lve; LAVV, left atrioventricular valve; TAPVC, total anomalous pulmonary venous connection; 
SVDA, systemic venous drainage anomalies; SP, systemic-pulmonary; PAB, pulmonary artery banding; PA, pulmonary artery;ASP, atrial septectomy; BCPA, 
bidirectional cavopulmonary anastomosis; AVv,, atrioventricular v lve. 
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similar to that in other reports, 9'14 was mostly due to 
the complex pathologic features, such as total anom- 
alous pulmonary venous connection and atrioven- 
tricular valve regurgitation. We believe that the 
worse outcome during the years 1992 and 1993 
could reflect our policy of extending the TECC 
operation to patients with more risk factors, em- 
boldened perhaps by the very good results obtained 
during the first 3 years of our experience with the 
TECC technique. 15Failure of the TECC operation 
occurred mostly in patients with severe pulmonary 
artery stenosis or hypoplasia nd a chronic volume 
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or pressure overload of the single ventricle resulting 
from age, long-standing systemic-pulmonary shunt, 
or atrioventricular valve regurgitation. The concept 
of staging Fontan-like operations in patients with 
complex congenital nomalies, including those with 
subaortic stenosis, by an intermediate BCPA treat- 
ing at the same time the subaortic stenosis, has been 
well established16: in fact, our results in that subset 
of patients upport his policy. Several reports 13' 17, 18 
have documented that-sudden reduction in total 
volume work of the single ventricle can result in 
rapid changes of ventricular geometry and increase 
in ventricular wail thickness. These changes may 
cause significant alterations in diastolic function 
with impaired filling of the ventricle. Hence more 
attention to ventricular geometry and dimensions in
patients who are candidates for a Fontan-type r pair 
should further improve surgical results. The in- 
creased risk of age younger than 4 years reported by 
several authors 19' 2o should be weighed against he 
deleterious effects of procedures that cause ventric- 
ular pressure or volume overload, myocardial hyper- 
trophy, or pulmonary artery distortion. 19-21 Because 
our results with the TECC operation in 16 patients 
under 4 years of age were very favorable, we con- 
tinue to recommend the TECC operation in the 
younger age group. One other concern regarding 
the TECC technique is the risk of late conduit 
obstruction. ManY reports dealing with prosthetic 
conduits in the venous circulation point out that 
obstruction occurs almost inevitably at some 
time.2a,23 Nevertheless, most of these reports de- 
scribe a mixed group of right heart conduits, valved 
or valveless, atriopulmonary or atrioventricular. 
Such conduits were usually placed in adverse hemo- 
dynamic conditions, for example, connected to a 
large atrium causing much turbulence and hence 
major isk of peel formation. Inasmuch as the TECC 
conduit relies on a more laminar hemodynamic flow 
pattern, there should be theoretically much less 
stimulus for peel formation. Unfortunately, very few 
of the largest reported series 22' 24, 25 contain data on 
the fate of nonvalved Dacron conduits used for right 
atrial-pulmonary artery connections. Some centers 
reported long-term patency with right-sided con- 
duits in patients who were treated with warfarin, 
aspirin, or dipyridamole, a6'27 Our data show that the 
small reduction in mean caliber observed uring the 
first 6 months after TECC does not progress over 
the following 5 years. Because the mechanism of 
peel thickening includes deposition of platelet-fibrin 
aggregates and thrombi between the peel itself and 
the conduit wall, 23 the use of anticoagulants, as in 
our experience, should prevent or at least minimize 
progression of peel thickening. The maximal reduc- 
tion in internal diameter measured in some patients 
was quantitatively important (around 1/3 of the cross 
section) and is therefore cause for concern. Perhaps 
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this reduction could be ascribed to changes in 
conduit shape, from circular to oval, which in turn 
could be the result of elongation of the conduits. 
Early in our experience, we made a concerted effort 
to minimize the amount of prosthetic material. This 
approach might have been ill advised, because a 
shorter conduit becomes more subject to incremen- 
tal longitudinal stretching forces. More recently, we 
have changed to polytetrafluoroethylene conduits 
(rather than Dacron conduits) and to a longer size, 
hoping to decrease the incidence of changing con- 
duit shape. 
Atrial arrhythmias are common complications, 
particularly during late follow-up after the Fontan 
operation (up to 40% in some series). 24' 28, 29 These 
arrhythmias are thought to be due to (1) scarring 
associated with suture lines, (2) stretching or dam- 
aging of the sinoatrial node area, (3) interference 
with its vascular supply during the cavopulmonary 
anastomosis, or (4) interference from high right 
atrial pressure and increased wall tension. Although 
the incidence of early and late arrhythmias appears 
to be somewhat less after TCPC than after other 
types of modified Fontan anastomoses, 2931 still a 
20% incidence of atrial arrhythmias is significant. 
Nevertheless, with the technique of electrical flutter 
inducibility, the incidence of only 7.4% of midterm 
arrhythmias is promising. Avoiding intraatrial su- 
ture lines may be one of the explanations for these 
findings, as recently demonstrated in dogs by Rode- 
feld and coworkers. 32 Our data so far suggest only a 
weak relationship between the occurrence of early 
versus late arrhythmias and also "longer" follow-up 
and late appearance of arrhythmias. The only pa- 
tient who had both early and late arrhythmias had 
surgical damage to the cavoatrial junction at the 
time of the BCPA. The other three patients had 
common atrial distention owing to significant atrio- 
ventricular valve incompetence. 
In conclusion, we believe that the TECC modifi- 
cation offers a simplified technique of right heart 
bypass and that it has the potential of reducing the 
risk of late atrial arrhythmias. Our initial concerns 
about possible conduit thrombotic obstruction, at 
least during this midterm follow-up, have been 
dispelled. At present we continue to use the TECC 
modification in all patients undergoing cavopulmo- 
nai2¢ bypass operations. 
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Discussion 
Dr. Leonard L. Bailey (Loma Linda, Calif.). Dr. 
Amodeo and his colleagues have been international lead- 
ers in the concept of e×tracardiac Fontan operations. As 
their experience expands, it becomes important for all of 
us to pay close attention to their outcomes, particularly in 
the long term. 
Extraeardiac routing of IVC blood flow to the pulmo- 
nary artery takes advantage of most of what we believe to 
be the best in Fontan reconstructive principles. It is 
simple, it is relatively safe in the short term, and it creates 
minimal atrial injury. The approach establishes rheologic 
patterns that conform to the suggestions ofMarc de Leval 
and associates. Also, this approach reduces the temporal 
phenomenon of atrial distention and hypertrophy and 
thus may translate into a reduction of late atrial arrhyth- 
mias. 
However, the extracardiac operations described by Dr. 
Amodeo are what I would consider complete, nonfenes- 
trated Fontan operations. These operations are being 
performed at a time when many, if not most, centers are 
using so-called fenestrated Fontan operations as the de- 
finitive procedure. To stay trendy, one could connect the 
extracardiac tube to the pulmonary venous atrium either 
in a side-by-side fashion directly or with a small H graft. 
The first question I have for Dr. Amodeo is this: Do you 
believe that the perioperative mortality and morbidity in 
this series could have been reduced by creating a fenes- 
trated or H-graft connection from the extracardiac venous 
conduit to the pulmonary venous atrium in selected 
patients? 
An additional long-term concern has to do with the 
low-velocity flow of blood in these conduits and ultimate 
conduit narrowing. Although there has not been short- 
term concern about conduit narrowing, all of us have seen 
these conduits 10 and 12 years later, and they tend to 
calcify and obstruct ultimately, particularly the Dacron 
conduits. 
Finally, my colleagues and I believe that the group from 
Rome has all the right principles in mind in the construc- 
tion of the Fontan procedure. Where we take exception is
in the use of a cylindric prosthetic graft to make the 
extracardiac connection from IVC to pulmonary arteries. 
My associate, Steven Gundry, has convinced me that in 
very nearly every case there is enough native pericardium 
with which to create an extracardiac in situ lateral tunnel 
that meets all of today's criteria for a good Fontan 
operation and requires no prosthetic material. In addition, 
Dr. Gundry's technique permits fenestration, if desired 
during the operation or later in the cardiac atheterization 
laboratory, if the patient is a marginal candidate (like 
many of the patients that you described) for Fontan 
physiology. We have used the extracardiac autologous 
pericardial tunnel, the so-called lateral tunnel, for the last 
18 completion Fontan operations performed at the Chil- 
dren's Hospital, Loma Linda University. None has been 
fenestrated. Early restudy of this recent innovation sug- 
gests that the approach as real promise. I am sure that 
Dr. Gundry will talk more about hat in months to come. 
Dr. Amodeo. Regarding the first question, I agree with 
you that now we have in our armamentarium the fenes- 
tration that could be incorporated as a direct anastomosis 
or as a small tube graft between the conduit and the 
atrium. I also agree with you that a fenestration probably 
could reduce the early mortality and morbidity in patients 
in whom the risk is high. In the future our patients 
probably will benefit from this modification. 
The second question raises some concerns related to 
the conduit in the venous system, especially Dacron 
conduits. If we look carefully at the literature, we find that 
most 10- to 15-year follow-up data reported include 
conduits in the worst hemodynamic and hydrodynamic 
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conditions. As the conduit interposed between the IVC 
and the pulmonary arteries relies on a better hydrody- 
namic pattern with uniform caliber through the pathway 
and less turbulence, we can speculate, and actually we are 
observing in this follow-up, that there could be less chance 
for obstruction. Some centers report good patency of right- 
sided conduits in patients treated with warfarin or aspirin. 
Our current policy is to use warfarin for the first 6 months 
and then move to aspirin. Of course, a longer follow-up will 
be needed to assess the late fate of this conduit. 
Dr. V. Mohan Reddy (San Francisco, Calif.). I have one 
question. Inasmuch as these conduits do not have any 
growth potential, is there any age preference now for 
when this operation should be done? If the patient is very 
young, do you still choose to use some other technique, or 
do you prefer to wait longer before you do this extracar- 
diac conduit Fontan procedure? 
Dr. Amodeo. There is no set preferential age for 
performing the extracardiac Fontan operation. Of course, 
because a lot of patients of this series received multiple 
previous palliative procedures and most of them have 
undergone staging with a BCPA, they can easily reach an 
age of 3 to 4 years. At this age a conduit can be inserted 
easily between 20 and 24 that is not far from the size of an 
adult IVC. Young age in our patients is not predictive for 
early failure. Our major concern at the beginning of the 
experience was related to the amount of prosthetic mate- 
rial (Dacron and successively polytetrafluoroethylene): for 
that reason, we tailored the conduit as short as possible in 
an effort to reduce the incidence of obstruction and 
thromboembolism. This could be the reason for the 
conduit shape anomalies that we are seeing in our mag- 
netic resonance imaging follow-up. We actually have 
increased the length of the conduits, making them less 
susceptible to longitudinal stretching forces related to 
child growth. If this is indeed the principal i medhanism of 
late obstruction, we could proceed as we did in a patient 
who was admitted to the hospital just 1 month ago. 
Magnetic resonance imaging showed that the conduit was 
obstructed more than 50% at the level of the distal 
anastomosis. We treated this patient by putting a stent in 
the conduit. An angiogram taken after stent implantation 
shows a normal diameter. This may suggest hat the 
mechanism of stenosis was not the accumulation of 
thrombotic material but an elongation and distortion of 
the conduit. 
